MarketInOut Stock Screener Log In | Sign Up

Laboratorios Farmaceuticos Rovi S.A.

BME • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Laboratorios Farmaceuticos Rovi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBME
Market Capitalization3,160.65 mln
Float16.18 mln
Earnings Date11/05/2026

EPS

3.62
Solid

P / E

17.28
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.57
Likely reliable

1-Year Forecast

73.69
Attractive

Relative Strength

94 / 100
Top performer

Business Description

Founded in 1946 and based near Madrid, Laboratorios Farmacéuticos Rovi is a Spanish pharmaceutical company that sells a broad range of prescription and hospital medicines across Europe and beyond, covering areas such as heart health, pain management, diagnostics, and respiratory care. The company also manufactures products on behalf of other pharmaceutical firms, handling everything from sterile filling and packaging to the application of safety devices for injectable and solid medicines. Rovi operates as part of the Norbel Inversiones group.

Key Fundamentals

EPS3.62
P/E17.28
ROE28.68
RPS15.11
ROIC15.25
ROA19.26
Interest Cover35.30
EBITDA, mln273
EV / EBITDA11.49
EV / EBIT13.11
Revenue, mln773
EV / Revenue4.06

Quote Details

Last 62.55
Change 1 (1.62%)
Open 61.75
Volume 111,662
Turnover 6,984,458
Average Volume 90,168

Financial Ratios

Pre-Tax Profit Margin30
Leverage Ratio1.61
Current Ratio2.05
Price / Book4.47
Price / Tangible Book4.72
Price / Cash Flow12.51
Price / Free Cash Flow17.59
Debt / Equity0.15
Price / Sales4.06
PEG Ratio1.15

Financial Strength

Altman Z-Score7.05
Piotroski F-Score 8 / 9
Beneish M-Score-2.57
Price to Intrinsic Value1.70
Price to Graham Number1.88
1-Year Target Price73.69
Shiller PE Ratio28.43

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.99% 87 / 100   
1 Month 9.07% 93 / 100   
2 Months 4.86% 82 / 100   
6 Months 0.94% 58 / 100   
1 Year 8.05% 54 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog